Lapatinib Completed Phase 2 Trials for Recurrent Ovarian Epithelial Cancer / Primary Peritoneal Cavity Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00113373Lapatinib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer